Trial intelligence / Profile preview

Early vs Late Warfarin Post-Caesarean in Mechanical Heart Valve Patients

NCT04855110Unknown

Sponsor
Cairo University
Start
Apr 2021
Primary completion
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of warfarin (2 arms), sponsored by Cairo University. Primary endpoints: Occurrence of subcutaneous and / or sub-rectus hematoma at 14 days, Occurrence of intra-abdominal bleeding at 14 days and 4 more. Status: unknown.

02

Drugs

warfarin

Beyond the preview

Go deeper on NCT04855110.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04855110.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call